Trademark: 88700173
Status Date
Friday, October 2, 2020
Filing Date
Wednesday, November 20, 2019
Abandoned Date
Tuesday, September 22, 2020
35 Administration of patient reimbursement programs in connection ozanimod; administering pharmacy reimbursement programs and services in connection ozanimod
44 Medical information and counseling in the field of ozanimod and safety issues pertaining to ozanimod, and providing medical information in connection with ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC) by distributing written materials in connection therewith; providing a web site featuring medical information on ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC); providing an internet website for medical professionals and medical patients featuring medical information on ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC); providing information relating to diagnostic, prophylactic and therapeutic properties of ozanimod; providing medical information, consultancy and advisory service in connection with ozanimod, multiple sclerosis (RMS) and ulcerative colitis (UC)
ZEPOSIA THREE HUNDRED SIXTY SUPPORT; ZEPOSIA THREE SIX ZERO SUPPORT; ZEPOSIA THREE SIXTY SUPPORT
Oct 2, 2020
Abandonment Notice E-Mailed - Failure To Respond
Oct 2, 2020
Abandonment - Failure To Respond Or Late Response
Mar 21, 2020
Notification Of Final Refusal Emailed
Mar 21, 2020
Final Refusal E-Mailed
Mar 21, 2020
Final Refusal Written
Feb 26, 2020
Teas/Email Correspondence Entered
Feb 26, 2020
Correspondence Received In Law Office
Feb 26, 2020
Teas Response To Office Action Received
Jan 6, 2020
Notification Of Non-Final Action E-Mailed
Jan 6, 2020
Non-Final Action E-Mailed
Jan 6, 2020
Non-Final Action Written
Dec 30, 2019
Assigned To Examiner
Nov 27, 2019
New Application Office Supplied Data Entered In Tram
Nov 23, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
